학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 360건 | 목록 1~20
Academic Journal
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Dirix LY; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium. luc.dirix@gza.be.; Oeyen S; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Buys A; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Liégois V; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Prové A; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Van De Mooter T; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Van Laere S; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.; Vermeulen PB; GZA Sint Augustinus, Oosterveldlaan 24, Wilrijk, 2610, Antwerp, Belgium.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Falchook GS; Drug Development Unit, Sarah Cannon Research Institute at HealthONE, 1800 Williams St Ste 300, Denver, CO, USA. Gerald.Falchook@SarahCannon.com.; Peeters M; Department of Oncology, University Antwerpen, Universitair Ziekenhuis Antwerpen, Drie Eikenstraat, Edegem, Belgium.; Rottey S; Drug Research Unit, Universitair Ziekenhuis Gent, Corneel Heymanslaan, Ghent, Belgium.; Dirix LY; Department of Medical Oncology, GZA Sint Augustinus, Oosterveldlaan, Wilrijk, Belgium.; Obermannova R; Comprehensive Cancer Care Department - Faculty of Medicine, Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Cohen JE; Department of Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Israel.; The Faculty of Medicine, The Wohl Institute for Translational Medicine, Hadassah Medical Center, Jerusalem, Israel.; Perets R; Department of Oncology, Clinical Research Institute at Rambam, Rambam Medical Center, Haifa, Israel.; Technion - Israel Institute of Technology, Haifa, Israel.; Frommer RS; The Ella Institute for Immuno-Oncology, Sheba Medical Center, Oncology Institute, Tel Hashomer, Ramat Gan, Israel.; Bauer TM; Department of Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.; Wang JS; Hematologic Oncology, Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA.; Carvajal RD; Department of Medicine, Division of Hematology/Oncology, Columbia University, College of Physicians and Surgeons, New York, NY, USA.; Sabari J; Department of Medicine,Medical Oncology, NYU Langone Health, New York, NY, USA.; Chapman S; Eli Lilly and Company, Windlesham, Surrey, UK.; Zhang W; Eli Lilly and Company, Indianapolis, IN, USA.; Calderon B; Eli Lilly and Company, Indianapolis, IN, USA.; Peterson DA; Eli Lilly and Company, Indianapolis, IN, USA.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands.; Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Van M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; De Laere B; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.; Dirix LY; GZA Hospitals Sint-Augustinus, Wilrijk, Belgium.; Center for Oncological Research, University of Antwerp, Antwerp, Belgium.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands.; Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.; Meulenbeld HJ; Department of Internal Medicine, Gelre Ziekenhuizen, Zutphen, The Netherlands.; Creemers GJ; Department of Internal Medicine, Catharina Ziekenhuis, Eindhoven, The Netherlands.; van Weerden WM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; Jenster GW; Department of Urology, Erasmus MC, Rotterdam, The Netherlands.; Nieuweboer AJM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Medical Oncology, Cancer Genomics Netherlands, Rotterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Academic Journal
Derks MGM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands c.j.h.van_de_velde@lumc.nl.; Giardiello D; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Seynaeve C; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.; Nortier JWR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Dirix LY; Oncology Center, Sint-Augustinus, Wilrijk-Antwerp, Belgium.; Bastiaannet E; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Liefers GJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Haider S; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada. Syed.Haider@oicr.on.ca.; Computer Laboratory, University of Cambridge, Cambridge, CB3 0FD, United Kingdom. Syed.Haider@oicr.on.ca.; Yao CQ; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, M5G 1L7, Canada.; Sabine VS; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Grzadkowski M; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Stimper V; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Starmans MHW; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Wang J; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Nguyen F; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, M5G 1L7, Canada.; Moon NC; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Lin X; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Drake C; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Crozier CA; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Brookes CL; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, B15 2TT, United Kingdom.; van de Velde CJH; Leiden University Medical Center, Leiden, The Netherlands.; Hasenburg A; University Hospital, Freiburg, Germany.; Kieback DG; Klinikum Vest Medical Center, Marl, Germany.; Markopoulos CJ; Athens University Medical School, Athens, Greece.; Dirix LY; St. Augustinus Hospital, Antwerp, Belgium.; Seynaeve C; Erasmus Medical Center-Daniel den Hoed, Rotterdam, The Netherlands.; Rea DW; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, B15 2TT, United Kingdom.; Kasprzyk A; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada.; Lambin P; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.; Lio' P; Computer Laboratory, University of Cambridge, Cambridge, CB3 0FD, United Kingdom.; Bartlett JMS; Diagnostic Development Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada. John.Bartlett@oicr.on.ca.; Boutros PC; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, M5G 0A3, Canada. paul.boutros@oicr.on.ca.; Department of Medical Biophysics, University of Toronto, Toronto, M5G 1L7, Canada. paul.boutros@oicr.on.ca.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, M5S 1A8, Canada. paul.boutros@oicr.on.ca.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Roseweir AK; School of Medicine, University of Glasgow, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Bennett L; School of Medicine, University of Glasgow, Glasgow, UK.; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Dickson A; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cheng K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Quintayo MA; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; Bayani J; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; McMillan DC; School of Medicine, University of Glasgow, Glasgow, UK.; Horgan PG; School of Medicine, University of Glasgow, Glasgow, UK.; van de Velde CJH; Leiden University Medical Centre, Leiden, the Netherlands.; Seynaeve C; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Hasenburg A; University Hospital Mainz, Mainz, Germany.; Kieback DG; Helios Medical Centre, Schleswig, Germany.; Markopoulos C; Athens University Medical School, Athens, Greece.; Dirix LY; St Augustinus Hospital, Antwerp, Belgium.; Rea DW; University of Birmingham, Birmingham, UK.; Mallon EA; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.; Bartlett JMS; Ontario Institute of Cancer Research, MaRS Institute, Toronto, Canada.; Edwards J; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst
검색 결과 제한하기
제한된 항목
[검색어] Dirix, LY
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어